GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 733 filers reported holding GLAXOSMITHKLINE PLC in Q4 2014. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $223,000 | -3.9% | 5,300 | -11.8% | 0.06% | -11.6% |
| Q4 2016 | $232,000 | -78.3% | 6,012 | -75.7% | 0.07% | -78.3% |
| Q3 2016 | $1,067,000 | +33.5% | 24,737 | +34.2% | 0.32% | +22.3% |
| Q2 2016 | $799,000 | +21.6% | 18,437 | +13.7% | 0.26% | +0.4% |
| Q1 2016 | $657,000 | +12.7% | 16,212 | +12.3% | 0.26% | +24.5% |
| Q4 2015 | $583,000 | +16.8% | 14,437 | +11.2% | 0.21% | +12.4% |
| Q3 2015 | $499,000 | -19.5% | 12,987 | -12.7% | 0.18% | -13.1% |
| Q2 2015 | $620,000 | +6.9% | 14,880 | +18.3% | 0.21% | +6.0% |
| Q1 2015 | $580,000 | +2421.7% | 12,577 | +2242.1% | 0.20% | +2412.5% |
| Q4 2014 | $23,000 | -45.2% | 537 | -41.2% | 0.01% | -50.0% |
| Q3 2014 | $42,000 | +31.2% | 914 | +53.1% | 0.02% | +33.3% |
| Q2 2014 | $32,000 | +10.3% | 597 | +11.2% | 0.01% | +9.1% |
| Q1 2014 | $29,000 | 0.0% | 537 | 0.0% | 0.01% | 0.0% |
| Q4 2013 | $29,000 | +7.4% | 537 | 0.0% | 0.01% | -8.3% |
| Q3 2013 | $27,000 | -27.0% | 537 | -27.1% | 0.01% | -33.3% |
| Q2 2013 | $37,000 | – | 737 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |